Compare MYGN & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | OI |
|---|---|---|
| Founded | 1991 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 2.3B |
| IPO Year | 1996 | 1994 |
| Metric | MYGN | OI |
|---|---|---|
| Price | $4.32 | $10.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $7.64 | ★ $16.86 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $771,400,000.00 | ★ $6,426,000,000.00 |
| Revenue This Year | $6.89 | $2.96 |
| Revenue Next Year | $5.35 | $1.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.76 | $9.23 |
| 52 Week High | $8.63 | $16.91 |
| Indicator | MYGN | OI |
|---|---|---|
| Relative Strength Index (RSI) | 37.15 | 33.49 |
| Support Level | $4.24 | $9.87 |
| Resistance Level | $5.69 | $13.59 |
| Average True Range (ATR) | 0.31 | 0.41 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 12.15 | 27.03 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.